Whole-body MR imaging in a multimodality world: Current applications, limitations, and future potential for comprehensive musculoskeletal imaging

Seminars in Musculoskeletal Radiology

Volumn 14, Issue 1, 2010, Pages 14-21

  Meaney, James F M ^a,b   Fagan, Andrew ^a  

^a ST JAMES S HOSPITAL   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

MR angiography; MR lymphography; WBMRI

Indexed keywords

BONE TUMOR; HISTOLOGY; HUMAN; LYMPHATIC SYSTEM; METASTASIS; MUSCULOSKELETAL SYSTEM; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; WHOLE BODY IMAGING;

BONE NEOPLASMS; HUMANS; LYMPHATIC SYSTEM; MAGNETIC RESONANCE IMAGING; MUSCULOSKELETAL SYSTEM; WHOLE BODY IMAGING;

EID: 77949495681     PISSN: 10897860     EISSN: 1098898X     Source Type: Journal    
DOI: 10.1055/s-0030-1248702     Document Type: Article

References (65)

1. Siegel M J. Magnetic resonance imaging of musculoskeletal soft tissue masses. Radiol Clin North Am 2001 39 (4) 701-720
2. Scḧder H, Larson S M. Positron emission tomography for prostate, bladder, and renal cancer. Semin Nucl Med 2004 34 (4) 274-292
3. Nazarian L N. The top 10 reasons musculoskeletal sonography is an important complementary or alternative technique to MRI. AJR Am J Roentgenol 2008 190 (6) 1621-1626
4. Smith N J., Shihab O, Arnaout A, Swift R I., Brown G. MRI for detection of extramural vascular invasion in rectal cancer. AJR Am J Roentgenol 2008 191 (5) 1517-1522
5. Abrahm J L., Banffy M B., Harris M B. Spinal cord compression in patients with advanced metastatic cancer: all I care about is walking and living my life JAMA 2008 299 (8) 937-946
6. Taylor F G., Swift R I., Blomqvist L, Brown G. A systematic approach to the interpretation of preoperative staging MRI for rectal cancer. AJR Am J Roentgenol 2008 191 (6) 1827-1835
7. Lall C G., Howard T J., Skandarajah A, DeWitt J M., Aisen A M., Sandrasegaran K. New concepts in staging and treatment of locally advanced pancreatic head cancer. AJR Am J Roentgenol 2007 189 (5) 1044-1050
8. Scḧder H, Herrmann K, Gönen M et al. 2-[18F]fluoro-2- deoxyglucose positron emission tomography for the detection of disease in patients with prostate-specific antigen relapse after radical prostatectomy. Clin Cancer Res 2005 11 (13) 4761-4769
9. Rinnab L, Mottaghy F M., Blumstein N M. et al. Evaluation of [11C]-choline positron-emission/computed tomography in patients with increasing prostate-specific antigen levels after primary treatment for prostate cancer. BJU Int 2007 100 (4) 786-793
10. Higton A M., Monach J, Congleton J. Investigation and management of lung cancer in older adults. Lung Cancer 2009 December 15 (Epub ahead of print)
11. Meaney J F. Magnetic resonance angiography of the peripheral arteries: current status. Eur Radiol 2003 13 (4) 836-852
12. Kalender W A., Seissler W, Klotz E, Vock P. Spiral volumetric CT with single-breath-hold technique, continuous transport, and continuous scanner rotation. Radiology 1990 176 (1) 181-183
13. Kapoor V, McCook B M., Torok F S. An introduction to PET-CT imaging. Radiographics 2004 24 (2) 523-543
14. Kapoor V, Fukui M B., McCook B M. Role of 18FFDG PET/CT in the treatment of head and neck cancers: principles, technique, normal distribution, and initial staging. AJR Am J Roentgenol 2005 184 (2) 579-587
15. Feng S, Ji J. Channel reduction in massive array parallel MRI. Conf Proc IEEE Eng Med Biol Soc 2009 1 4045-4048
16. Wright S M., McDougall M P., Feng K, Hollingsworth N A., Bosshard J C., Chang C W. Highly parallel transmit/receive systems for dynamic MRI. Conf Proc IEEE Eng Med Biol Soc 2009 1 4053-4056
17. Kruger D G., Riederer S J., Grimm R C., Rossman P J. Continuously moving table data acquisition method for long FOV contrast-enhanced MRA and whole-body MRI. Magn Reson Med 2002 47 (2) 224-231
18. Kramer H, Zenge M, Schmitt P, Glaser C, Reiser M F., Herrmann K A. Peripheral magnetic resonance angiography (MRA) with continuous table movement at 3.0 T: initial experience compared with step-by-step MRA. Invest Radiol 2008 43 (9) 627-634
19. Eustace S, Tello R, DeCarvalho V et al. A comparison of whole-body turboSTIR MR imaging and planar 99mTc-methylene diphosphonate scintigraphy in the examination of patients with suspected skeletal metastases. AJR Am J Roentgenol 1997 169 (6) 1655-1661
20. Puls R, Kuhn J P., Ewert R, Hosten N. Whole-body magnetic resonance imaging for staging of lung cancer. Front Radiat Ther Oncol 2010 42 46-54
21. Lütje S, de Rooy J W., Croockewit S, Koedam E, Oyen W J., Raymakers R A. Role of radiography, MRI and FDG-PET/CT in diagnosing, staging and therapeutical evaluation of patients with multiple myeloma. Ann Hematol 2009 88 (12) 1161-1168
22. B̈uerle T, Hillengass J, Fechtner K et al. Multiple myeloma and monoclonal gammopathy of undetermined significance: importance of whole-body versus spinal MR imaging. Radiology 2009 252 (2) 477-485
23. Daldrup-Link H E., Franzius C, Link T M. et al. Whole-body MR imaging for detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG PET. AJR Am J Roentgenol 2001 177 (1) 229-236
24. Gutzeit A, Doert A, Froehlich J M. et al. Comparison of diffusion-weighted whole body MRI and skeletal scintigraphy for the detection of bone metastases in patients with prostate or breast carcinoma. Skeletal Radiol 2009 Sep 8
25. Rubens R D. Bone metastasesthe clinical problem. Eur J Cancer 1998 34 (2) 210-213
26. Lecouvet F E., Malghem J, Michaux L et al. Skeletal survey in advanced multiple myeloma: radiographic versus MR imaging survey. Br J Haematol 1999 106 (1) 35-39
27. Imamura F, Kuriyama K, Seto T et al. Detection of bone marrow metastases of small cell lung cancer with magnetic resonance imaging: early diagnosis before destruction of osseous structure and implications for staging. Lung Cancer 2000 27 (3) 189-197
28. Steinborn M M., Heuck A F., Tiling R, Bruegel M, Gauger L, Reiser M F. Whole-body bone marrow MRI in patients with metastatic disease to the skeletal system. J Comput Assist Tomogr 1999 23 (1) 123-129
29. Lauenstein T C., Freudenberg L S., Goehde S C. et al. Whole-body MRI using a rolling table platform for the detection of bone metastases. Eur Radiol 2002 12 (8) 2091-2099
30. Antoch G, Vogt F M., Freudenberg L S. et al. Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology. JAMA 2003 290 (24) 3199-3206
31. Ghanem N, Lohrmann C, Engelhardt M et al. Whole-body MRI in the detection of bone marrow infiltration in patients with plasma cell neoplasms in comparison to the radiological skeletal survey. Eur Radiol 2006 16 (5) 1005-1014
32. Walker R, Kessar P, Blanchard R et al. Turbo STIR magnetic resonance imaging as a whole-body screening tool for metastases in patients with breast carcinoma: preliminary clinical experience. J Magn Reson Imaging 2000 11 (4) 343-350
33. Antoch G, Saoudi N, Kuehl H et al. Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET. J Clin Oncol 2004 22 (21) 4357-4368
34. Biederer J, Hintze C, Fabel M. MRI of pulmonary nodules: technique and diagnostic value. Cancer Imaging 2008 8 125-130
35. Boss A, Schaefer S, Martirosian P, Claussen C D., Schick F, Schaefer J F. Magnetic resonance imaging of lung tissue: influence of body positioning, breathing and oxygen inhalation on signal decay using multi-echo gradient-echo sequences. Invest Radiol 2008 43 (6) 433-438
36. Fink C, Puderbach M, Biederer J et al. Lung MRI at 1.5 and 3 Tesla: observer preference study and lesion contrast using five different pulse sequences. Invest Radiol 2007 42 (6) 377-383
37. Jansen J F., Stambuk H E., Koutcher J A., Shukla-Dave A. Non-Gaussian analysis of diffusion-weighted MR imaging in head and neck squamous cell carcinoma: a feasibility study. AJNR Am J Neuroradiol 2009
38. Kim C K., Park B K., Kim B. High-b-value diffusion-weighted imaging at 3 T to detect prostate cancer: comparisons between b values of 1,000 and 2,000 s/mm2. AJR Am J Roentgenol 2010 194 (1) W337
39. Eiber M, Beer A J., Holzapfel K et al. Preliminary results for characterization of pelvic lymph nodes in patients with prostate cancer by diffusion-weighted MR-imaging. Invest Radiol 2010 45 (1) 15-23
40. Liu Y, Bai R, Sun H, Liu H, Wang D. Diffusion-weighted magnetic resonance imaging of uterine cervical cancer. J Comput Assist Tomogr 2009 33 (6) 858-862
41. Nakayama J, Miyasaka K, Omatsu T et al. Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: quantitative assessment with diffusion-weighted magnetic resonance imaging and apparent diffusion coefficient. J Comput Assist Tomogr 2010 34 (1) 1-8
42. Barajas R F. Jr, Rubenstein J L., Chang J S., Hwang J, Cha S. Diffusion-weighted MR imaging derived apparent diffusion coefficient is predictive of clinical outcome in primary central nervous system lymphoma. AJNR Am J Neuroradiol 2009 October 8 (Epub ahead of print)
43. Kim S H., Cha E S., Kim H S. et al. Diffusion-weighted imaging of breast cancer: correlation of the apparent diffusion coefficient value with prognostic factors. J Magn Reson Imaging 2009 30 (3) 615-620
44. Hamm B. Iron-oxide-enhanced MR lymphography: just a new toy or a breakthrough? Eur Radiol 2002 12 (5) 957-958
45. Harisinghani M G., Barentsz J O., Hahn P F. et al. MR lymphangiography for detection of minimal nodal disease in patients with prostate cancer. Acad Radiol 2002 9 (suppl 2) S312-S313
46. Golder W A. Lymph node diagnosis in oncologic imaging: a dilemma still waiting to be solved. Onkologie 2004 27 (2) 194-199
47. Prince M R. Gadolinium-enhanced MR aortography. Radiology 1994 191 (1) 155-164
48. Prince M R., Narasimham D L., Stanley J C. et al. Breath-hold gadolinium-enhanced MR angiography of the abdominal aorta and its major branches. Radiology 1995 197 (3) 785-792
49. Meaney J F., Ridgway J P., Chakraverty S et al. Stepping-table gadolinium-enhanced digital subtraction MR angiography of the aorta and lower extremity arteries: preliminary experience. Radiology 1999 211 (1) 59-67
50. Ruehm S G., Goyen M, Barkhausen J et al. Rapid magnetic resonance angiography for detection of atherosclerosis. Lancet 2001 357 (9262) 1086-1091
51. Zhang H L., Ho B Y., Chao M et al. Decreased venous contamination on 3D gadolinium-enhanced bolus chase peripheral MR angiography using thigh compression. AJR Am J Roentgenol 2004 183 (4) 1041-1047
52. Kramer H, Quick H H., Tombach B, Schoenberg S O., Barkhausen J. Whole-body MRA. Eur Radiol 2008 18 (9) 1925-1936
53. Weckbach S, Schoenberg S O. Whole body MR imaging in diabetes. Eur J Radiol 2009 70 (3) 424-430
54. Waugh S A., Ramkumar P G., Gandy S J. et al. Optimization of the contrast dose and injection rates in whole-body MR angiography at 3.0T. J Magn Reson Imaging 2009 30 (5) 1059-1067
55. Kramer H, Morana G. Whole-body magnetic resonance angiography with blood-pool agents. Eur Radiol 2007 17 (suppl 2) B24-B29
56. Klessen C, Hein P A., Huppertz A et al. First-pass whole-body magnetic resonance angiography (MRA) using the blood-pool contrast medium gadofosveset trisodium: comparison to gadopentetate dimeglumine. Invest Radiol 2007 42 (9) 659-664
57. Miller T T. MR imaging of the knee. Sports Med Arthrosc 2009 17 (1) 56-67
58. Murray P J., Shaffer B S. Clinical update: MR imaging of the shoulder. Sports Med Arthrosc 2009 17 (1) 40-48
59. Rennie W J., Dhillon S S., Conner-Spady B, Maksymowych W P., Lambert R G. Magnetic resonance imaging assessment of spinal inflammation in ankylosing spondylitis: standard clinical protocols may omit inflammatory lesions in thoracic vertebrae. Arthritis Rheum 2009 61 (9) 1187-1193
60. Weber U, Hodler J, Kubik R A. et al. Sensitivity and specificity of spinal inflammatory lesions assessed by whole-body magnetic resonance imaging in patients with ankylosing spondylitis or recent-onset inflammatory back pain. Arthritis Rheum 2009 61 (7) 900-908
61. Weber U, Maksymowych W P., Jurik A G. et al. Validation of whole-body against conventional magnetic resonance imaging for scoring acute inflammatory lesions in the sacroiliac joints of patients with spondylarthritis. Arthritis Rheum 2009 61 (7) 893-899
62. Mager A K., Althoff C E., Sieper J, Hamm B, Hermann K G. Role of whole-body magnetic resonance imaging in diagnosing early spondyloarthritis. Eur J Radiol 2009 71 (2) 182-188
63. Maksymowych W P. MRI in ankylosing spondylitis. Curr Opin Rheumatol 2009 21 (4) 313-317
64. Althoff C E., Appel H, Rudwaleit M et al. Whole-body MRI as a new screening tool for detecting axial and peripheral manifestations of spondyloarthritis. Ann Rheum Dis 2007 66 (7) 983-985
65. Baraliakos X, Landew R, Hermann K G. et al. Inflammation in ankylosing spondylitis: a systematic description of the extent and frequency of acute spinal changes using magnetic resonance imaging. Ann Rheum Dis 2005 64 (5) 730-734